1. Home
  2. HOFT vs BDTX Comparison

HOFT vs BDTX Comparison

Compare HOFT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hooker Furnishings Corporation

HOFT

Hooker Furnishings Corporation

HOLD

Current Price

$15.43

Market Cap

160.4M

ML Signal

HOLD

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

HOLD

Current Price

$1.95

Market Cap

171.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HOFT
BDTX
Founded
1924
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.4M
171.9M
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
HOFT
BDTX
Price
$15.43
$1.95
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$9.67
AVG Volume (30 Days)
55.3K
684.3K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
3.79%
N/A
EPS Growth
N/A
130.71
EPS
0.10
N/A
Revenue
$278,139,000.00
N/A
Revenue This Year
$17.37
N/A
Revenue Next Year
$9.00
N/A
P/E Ratio
$151.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.62
$1.60
52 Week High
$18.09
$4.94

Technical Indicators

Market Signals
Indicator
HOFT
BDTX
Relative Strength Index (RSI) 55.46 56.24
Support Level $15.08 $1.76
Resistance Level $15.97 $2.26
Average True Range (ATR) 0.77 0.09
MACD 0.14 0.02
Stochastic Oscillator 81.50 95.24

Price Performance

Historical Comparison
HOFT
BDTX

About HOFT Hooker Furnishings Corporation

Hooker Furnishings Corp is a designer, marketer, and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality, and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segments: Hooker Branded segment, Domestic Upholstery segment, and All Other. It generates the majority of its revenue from the Hooker Branded segment.

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

Share on Social Networks: